This issue of Surgical Oncology Clinics of North America focuses on Immunotherapy for Solid Malignancies and is edited by Dr. Alfred E. Chang. Articles will include: Current immunotherapy practices for melanoma; Immunotherapy for ovarian cancer; Vaccines therapies for melanoma; Vaccine therapies for breast cancer; Induced pleuripotent T cells for adoptive immunotherapy; Future research goals in immunotherapy; Oncolytic immunotherapy; Adoptive T cell therapy for solid malignancies; Checkpoint inhibition immunotherapy; Toxicities of immunotherapy agents; Immunologic targeting of cancer stem cells; Role of surgery in combination with immunotherapy; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. Vaccine Strategy in Melanoma - p. 337 10. Vaccine Therapies for Breast Cancer - p. 353 11. The Current Landscape of Immune Checkpoint Inhibition for Solid Malignancies - p. 369 12. Immunotherapy Toxicities - p. 387 13. Current Immunotherapy Practices in Melanoma - p. 403 14. Oncolytic Immunotherapy - p. 419 15. Immunologic Targeting of Cancer Stem Cells - p. 431 16. Immunotherapy in Ovarian Cancer - p. 447 17. Adoptive T-Cell Therapy for Solid Malignancies - p. 465 18. Role of Surgery in Combination with Immunotherapy - p. 481 19. Induced Pluripotent Stem Cell-Derived T Cells for Cancer Immunotherapy - p. 489 20. Future Research Goals in Immunotherapy - p. 505
No hay muestra disponible
No hay ficha técnica disponible
This issue of Surgical Oncology Clinics of North America focuses on Immunotherapy for Solid Malignancies and is edited by Dr. Alfred E. Chang. Articles will include: Current immunotherapy practices for melanoma; Immunotherapy for ovarian cancer; Vaccines therapies for melanoma; Vaccine therapies for breast cancer; Induced pleuripotent T cells for adoptive immunotherapy; Future research goals in immunotherapy; Oncolytic immunotherapy; Adoptive T cell therapy for solid malignancies; Checkpoint inhibition immunotherapy; Toxicities of immunotherapy agents; Immunologic targeting of cancer stem cells; Role of surgery in combination with immunotherapy; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. Vaccine Strategy in Melanoma - p. 337 10. Vaccine Therapies for Breast Cancer - p. 353 11. The Current Landscape of Immune Checkpoint Inhibition for Solid Malignancies - p. 369 12. Immunotherapy Toxicities - p. 387 13. Current Immunotherapy Practices in Melanoma - p. 403 14. Oncolytic Immunotherapy - p. 419 15. Immunologic Targeting of Cancer Stem Cells - p. 431 16. Immunotherapy in Ovarian Cancer - p. 447 17. Adoptive T-Cell Therapy for Solid Malignancies - p. 465 18. Role of Surgery in Combination with Immunotherapy - p. 481 19. Induced Pluripotent Stem Cell-Derived T Cells for Cancer Immunotherapy - p. 489 20. Future Research Goals in Immunotherapy - p. 505
No hay muestra disponible
No hay ficha técnica disponible
